PAI-1 upregulation is an early event in the progression of incipient epidermal SCC, often localizing to tumor cells and cancer-associated myofibroblasts at the invasive front [54–56] and, more importantly, is a marker with significant prognostic value [43–46]. This evidence concerns the gene SERPINE1 and neoplasm.